期刊文献+

克罗恩病合并红斑肢痛症1例报告及文献复习 被引量:1

Crohn's disease complicated with erythromelalgia: report of 1 case and literature review
暂未订购
导出
摘要 目的探讨克罗恩病(Crohn’s disease,CD)合并红斑肢痛症(erythromelalgia,EM)的临床特点及其诊断和治疗。方法整理分析1例克罗恩病合并红斑肢痛症的13岁女童的临床表现、实验室和内镜检查结果、SCN9A基因分析和随访资料,并进行相关文献复习。结果患儿临床表现为食欲减退、乏力伴腹泻,双下肢端皮肤肿胀呈暗红色,肤温高并伴烧灼样疼痛。内镜检查见结肠呈多发性溃疡和息肉样隆起,病理检查提示为结肠黏膜局部脓肿形成。基因分析排除SCN9A基因突变。经口服泼尼松和美沙拉嗪,并联合双嘧达莫和低分子肝素钙治疗后,患儿临床症状渐获缓解。结论克罗恩病合并红斑肢痛症罕见,其发病机制可能与免疫因素、血小板增多和血液高凝状态等因素有关。应用糖皮质激素和5-氨基水杨酸并联合抗凝药物治疗可获得较好疗效。 Objectives To explore the clinical features,diagnosis and treatment of Crohn’s disease complicated by erythromelalgia(EM) in a pediatric case.Methods The clinical manifestation,results of laboratory testing and endoscopy,mutational analysis of the SCN9A gene,and the follow-up record were collected and analyzed based on review of literature to a thirteen-year-old girl with Crohn’s disease complicated by erythromelalgia.Results The patient experienced symptoms of anorexia,fatigue,diarrhea,dark red and swelling skin,increased skin temperature and burning pain in her both lower extremities during the course of disease.The endoscopic findings included multiple ulcerations and polypoid protrusion lesion in colon,and the pathological examination showed the local abscess formation in colonic mucosa.The mutation in SCN9A gene of the child was excluded by gene analysis.The symptoms were gradually ameliorated after treatment using prednisone and mesalazine combined with dipyridamole and low-molecular-weight heparin calcium.Conclusions Crohn’s disease complicated by erythromelalgia is rare.The pathogenesis may relate to immune factors,thrombocytosis,and hypercoagulable states,etc.The combination of glucocorticoids,5-aminosalicylic acid and anticoagulants may lead to a better therapeutic effect.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2013年第8期774-778,共5页 Journal of Clinical Pediatrics
关键词 克罗恩病 红斑肢痛症 内镜检查 肠外表现 发病机制 Crohn’s disease erythromelalgia endoscopy extraintestinal manifestations pathogenesis
  • 相关文献

参考文献3

二级参考文献92

  • 1Bernstin CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost, 2001,85 : 430-434.
  • 2Quera R, Shanahan F. Thromboembotism-an important manifestation of inflammatory bowel disease. Am J Gastroenterol, 2004,99 : 1971-1973.
  • 3Bouma BN, Mosnier LO. Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and frbrinolysis. Pathophysiol Haemost Thromb, 2003 2004, 33:375-381.
  • 4Sutherland LR, Mattin F, Greer S, et al. 5-Aminosalicyclic acid enema in the treatment of distal ulcerative colitis, proctrosigmoditis, and proctitis. Gastroenterology, 1987, 92:1894-1898.
  • 5Harvey RF, Bradshaw JM. A simple index of Crohn' s- disease activity. Lancet, 1980,1 : 514.
  • 6Andoh A, Yoshida T, Yagi Y, et al. Increased aggregation response of platelets in patients with inflammatory bowel disease. J Gastroenterol,2006,41:47-54.
  • 7Morowitz DA, Allen LW, Kirsner JB. Thrombocytosis in chronic inflammatory bowel disease. Ann Intern Med, 1968: 68:1013-1021.
  • 8Danese S, Kattz JA, Saibeni S, et at. Activated platelats are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease. Gut, 2003, 52: 1435-1441.
  • 9Collins CE, Rampton DS, Rogers J, et al. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol, 1997,9 : 1213-1217.
  • 10Mary JY,Modigliani R.Development and validation of an endoscopic index of the severity for Crohn's disease:a prospective multicentre study.Groupe d' Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).Gut,1989,30:983-989.

共引文献14

同被引文献29

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部